From: Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines
LLD | median | IQR | ||
---|---|---|---|---|
IL1α | 6.664 | EPA | 6.66 | (6.66,13.9) |
DHA | 6.66 | (6.66,6.66) | ||
Placebo | 6.66 | (6.66,13.1) | ||
IL1β | 7.806 | EPA | 7.81 | (7.81,60.1) |
DHA | 7.81 | (7.81,47.4) | ||
Placebo | 25.9 | (7.81,72.7) | ||
IL2 | 2.584 | EPA | 33.7 | (2.58,81.7) |
DHA | 39.0 | (21.8,69.2) | ||
Placebo | 32.5 | (13.4,52.1) | ||
IL4 | 0.776 | EPA | 0.776 | (0.78,5.2) |
DHA | 0.776 | (0.78,4) | ||
Placebo | 1.80 | (0.78,5.4) | ||
IL5 | 35.05 | EPA | 35.1 | (35.1114) |
DHA | 35.1 | (35.1,84.8) | ||
Placebo | 35.1 | (35.1124) | ||
IL6 | 18.466 | EPA | 20.1 | (18.5,65.1) |
DHA | 23.2 | (18.5,66) | ||
Placebo | 18.5 | (18.5,40.7) | ||
IL8 | 9.894 | EPA | 35.7 | (9.89,83) |
DHA | 10.5 | (9.89,55.9) | ||
Placebo | 12.3 | (9.89,75.5) | ||
IL10 | 2.94 | EPA | 2.94 | (2.94,41.7) |
DHA | 2.94 | (2.94,36.3) | ||
Placebo | 2.94 | (2.94,56.5) | ||
IL12p70 | 45.458 | EPA | 45.5 | (45.5198) |
DHA | 45.5 | (45.5,45.5) | ||
Placebo | 45.5 | (45.5150) | ||
IL13 | 12.608 | EPA | 12.6 | (12.6,67.3) |
DHA | 12.6 | (12.6,36.3) | ||
Placebo | 12.6 | (12.6,54.9) | ||
IL15 | 7.734 | EPA | 7.73 | (7.73,20.1) |
DHA | 7.73 | (7.73,7.73) | ||
Placebo | 7.73 | (7.73,7.73) | ||
IL17 | 45.586 | EPA | 45.6 | (45.6,62.6) |
DHA | 45.6 | (45.6,45.6) | ||
Placebo | 45.6 | (45.6,65.8) | ||
IFNγ | 58.506 | EPA | 58.5 | (58.5188) |
DHA | 58.5 | (58.5193) | ||
Placebo | 58.5 | (58.5200) | ||
MPC1 | 5.686 | EPA | 309 | (192,509) |
DHA | 277 | (188,473) | ||
Placebo | 288 | (171,404) | ||
TNFα | 15.146 | EPA | 15.1 | (15.1101) |
DHA | 15.1 | (15.1,78) | ||
Placebo | 15.1 | (15.1,30.9) | ||
TNFβ | 4.956 | EPA | 4.96 | (4.96,19.4) |
DHA | 4.96 | (4.96,4.96) | ||
Placebo | 4.96 | (4.96,12.9) |